Brand-name GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are manufactured by pharmaceutical companies, undergo extensive FDA clinical trials, and are approved as finished drug products with fixed dosing options
A vial that sat in a hot car for three hours may look identical to a fresh one, but the active compound inside could be partially or fully degraded
Even a single, well-prepared, evidence-based contribution can influence outcomes
Medicare Coverage of Anti-Obesity Medications (Issue Brief No
It took the brand manufacturers more than two years to build enough capacity for the FDA to declare the shortages over, which happened on December 19, 2024, for Eli Lillys tirzepatide products, and February 21, 2025, for Novo Nordisks semaglutide products
Many states now cover Wegovy for this indication even if they dont cover it for weight loss alone